SCHEMBL24756944

SCHEMBL24756944

Cc1[nH]c(=S)cc2cccc(F)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.42
▸ PARP1 P09874 1/20 0.39
▸ DAO P14920 1/20 0.33
▸ DDO Q99489 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ HRH4 Q9H3N8 1/20 0.32
▸ GAA P10253 3/20 0.31
▸ LMNA P02545 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ PDE7A Q13946 2/20 0.31
▸ GFER P55789 1/20 0.31
▸ ATM Q13315 1/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ MAPT P10636 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24756943 0.79 CYP1A2 (0.69) CYP1A2PARP1DAODDOALDH1A1
SCHEMBL24757550 0.69 ALDH1A1 (0.60) CYP1A2ALDH1A1HPGDALOX15HSD17B10
SCHEMBL29914966 0.68 PARP1 (0.54) CYP1A2PARP1DAODDOCA12
SCHEMBL20967267 0.67 CYP2A6 (0.39) CYP1A2PARP1KDM4EACHE
SCHEMBL5249445 0.67 ACHE (0.41) CYP1A2PARP1ALDH1A1HPGDHSD17B10
SCHEMBL4112541 0.63 ALDH1A1 (0.53) CYP1A2PARP1ALDH1A1HPGDHSD17B10
SCHEMBL29788341 0.63 ALDH1A1 (0.53) CYP1A2PARP1ALDH1A1HPGDHSD17B10
SCHEMBL20356021 0.63 CYP1A2 (0.42) CYP1A2PARP1DAODDOALDH1A1
SCHEMBL14596479 0.63 ACHE (0.52) CYP1A2PARP1ALDH1A1HPGDHSD17B10
SCHEMBL24652317 0.63 MEN1 (0.46) CYP1A2DAODDOALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022266206-A1 KRAS INHIBITOR CONJUGATES ERASCA, INC. (US) 2022-12-22 — — WO disclosed
Send feedback